Integra Lifesciences Holdings Corp (IART)
23.71
+0.40
(+1.72%)
USD |
NASDAQ |
Nov 14, 10:46
Integra Lifesciences Holdings Revenue (Annual): 1.542B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.542B |
| December 31, 2022 | 1.558B |
| December 31, 2021 | 1.542B |
| December 31, 2020 | 1.372B |
| December 31, 2019 | 1.518B |
| December 31, 2018 | 1.472B |
| December 31, 2017 | 1.188B |
| December 31, 2016 | 992.08M |
| December 31, 2015 | 882.73M |
| December 31, 2014 | 796.72M |
| December 31, 2013 | 696.83M |
| December 31, 2012 | 830.87M |
| December 31, 2011 | 780.08M |
| December 31, 2010 | 732.07M |
| December 31, 2009 | 682.49M |
| Date | Value |
|---|---|
| December 31, 2008 | 654.60M |
| December 31, 2007 | 550.46M |
| December 31, 2006 | 419.30M |
| December 31, 2005 | 277.94M |
| December 31, 2004 | 229.82M |
| December 31, 2003 | 185.60M |
| December 31, 2002 | 112.62M |
| December 31, 2001 | 87.69M |
| December 31, 2000 | 64.99M |
| December 31, 1999 | 40.05M |
| December 31, 1998 | 14.18M |
| December 31, 1997 | 14.70M |
| December 31, 1996 | 13.10M |
| December 31, 1995 | 10.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.372B
Minimum
2020
1.558B
Maximum
2022
1.506B
Average
1.542B
Median
2023
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| ResMed Inc | 4.685B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |